Quantcast
Last updated on April 21, 2014 at 7:52 EDT

Latest Peyronie's disease Stories

2013-08-01 08:35:15

LYNBROOK, N.Y., Aug. 1, 2013 /PRNewswire/ -- BioSpecifics Technologies Corp. (NASDAQ: BSTC), a biopharmaceutical company developing first in class collagenase-based products marketed as XIAFLEX(®) in the U.S. and XIAPEX(®)( )in the EU, announced today that it will host a conference call and live audio webcast at 8:30 a.m. EDT on Thursday, August 8, 2013 to report its second quarter 2013 financial results and provide a corporate update. In order to participate in the conference...

2013-08-01 08:33:36

- 2Q13 Total Net Revenues Increased by 29% vs. 2Q12 to $100.5 MM - CHESTERBROOK, Pa., Aug. 1, 2013 /PRNewswire/ -- Auxilium Pharmaceuticals, Inc. (Nasdaq: AUXL), a specialty biopharmaceutical company, today announced financial results for the quarter ending on June 30, 2013. The Company also highlighted select commercial, regulatory and clinical development progress in the second quarter of 2013 and has updated its previously announced financial guidance for 2013. (Logo:...

2013-07-24 08:29:36

CHESTERBROOK, Pa., July 24, 2013 /PRNewswire/ -- Auxilium Pharmaceuticals, Inc. (NASDAQ: AUXL), a specialty biopharmaceutical company, will release results for the second quarter 2013 on Thursday, August 1, 2013. The Company will also conduct a conference call that day at 10:00 a.m. ET to discuss results and highlights of the second quarter. The presentation slides to be used during the call will be available on the "For Investors" section of the Company's web site under the...

2013-07-23 08:31:30

LYNBROOK, N.Y., July 23, 2013 /PRNewswire/ -- BioSpecifics Technologies Corp. (NASDAQ: BSTC), a biopharmaceutical company developing first in class collagenase-based products marketed as XIAFLEX(®) (collagenase clostridium histolyticum; CCH) in the U.S., announces that a poster titled, "Biomechanical Evaluation of Human Uterine Fibroids after Exposure to Purified Clostridial Collagenase" was presented today at the Society for the Study of Reproduction 46(th) Annual Meeting taking...

2013-07-16 20:21:37

LYNBROOK, N.Y., July 16, 2013 /PRNewswire/ -- BioSpecifics Technologies Corp. (NASDAQ: BSTC), a biopharmaceutical company developing first in class collagenase-based products marketed as XIAFLEX(®) in the U.S, today announced that its partner Auxilium Pharmaceuticals, Inc. (Auxilium) has entered into a collaboration with Swedish Orphan Biovitrum AB (Sobi) for the long-term development, supply and commercialization of XIAPEX (collagenase clostridium histolyticum) for the treatment of...

2013-07-16 00:20:42

-Sobi Obtains Exclusive Rights for One Commercial and One Development Indication for XIAPEX- CHESTERBROOK, Pa., and STOCKHOLM, July 16, 2013 /PRNewswire/ -- Auxilium Pharmaceuticals, Inc. (NASDAQ: AUXL) and Swedish Orphan Biovitrum AB (publ) (STO: SOBI) announced today that they have entered into a long-term collaboration for the development, supply and commercialization of XIAPEX (collagenase clostridium histolyticum), a novel, first-in-class biologic for the treatment of...

2013-07-03 08:24:26

CHESTERBROOK, Pa., July 3, 2013 /PRNewswire/ -- Auxilium Pharmaceuticals, Inc. (Nasdaq: AUXL) today announced that executive management will participate in the 8th Annual JMP Securities Healthcare Conference to be held July 9-10, 2013 at the St. Regis hotel in New York City. Mr. Adrian Adams, Chief Executive Officer and President, is scheduled to present an overview of the Company and its product pipeline at 9:30 a.m. ET on Wednesday, July 10, 2013. (Logo:...

2013-07-02 08:26:12

LYNBROOK, N.Y., July 2, 2013 /PRNewswire/ -- BioSpecifics Technologies Corp. (NASDAQ: BSTC), a biopharmaceutical company developing first in class collagenase-based products marketed as XIAFLEX(®) in the U.S., today announced that BioSpecifics' President, Tom Wegman, will present a corporate overview at the 8(th) Annual JMP Securities Healthcare Conference at 4:00 p.m. EDT on Wednesday, July 10, 2013 in New York, NY. The live webcast of this presentation can be accessed under...

2013-06-11 08:30:20

National Survey Reveals Gaps in Perceptions and Realities of Living with Peyronie's Disease, as Experienced by Both Men and Their Partners WASHINGTON, and CHESTERBROOK, Pa., June 11, 2013 /PRNewswire/ -- Men's Health Network ("MHN") and Auxilium Pharmaceuticals, Inc. (NASDAQ: AUXL), a specialty biopharmaceutical company, have announced the launch of a new health awareness program called "Ask About the Curve" to provide information about Peyronie's disease (PD) and to help empower men...

2013-06-07 08:24:33

CHESTERBROOK, Pa., June 7, 2013 /PRNewswire/ -- Auxilium Pharmaceuticals, Inc. (Nasdaq: AUXL) today announced that executive management will participate in the Goldman Sachs 34th Annual Global Healthcare Conference to be held June 11-13, 2013 at the Terranea Hotel in Rancho Palos Verdes, CA. Mr. Adrian Adams, Chief Executive Officer and President, is scheduled to present an overview of the Company and its product pipeline at 10:40 a.m. PT (1:40 p.m. ET) on Thursday, June 13, 2013. (Logo:...